Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Pancreatic Neoplasms D010190 77 associated lipids
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Lewis-Barned NJ et al. Plasma cholesterol esterification and transfer, the menopause, and hormone replacement therapy in women. 1999 J. Clin. Endocrinol. Metab. pmid:10522991
Tran A et al. Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study. 1999 Am. J. Gastroenterol. pmid:10520843
el Nahal N et al. Acceptability of once-a-month injectable contraceptives Cyclofem and Mesigyna: focus group discussion. 1999 Contraception pmid:10518231
Bjarnason K et al. Adverse endometrial effects during long cycle hormone replacement therapy. Scandinavian Long Cycle Study Group. 1999 Maturitas pmid:10515673
Archer DF et al. A randomized comparison of continuous combined transdermal delivery of estradiol-norethindrone acetate and estradiol alone for menopause. CombiPatch Study Group. 1999 Obstet Gynecol pmid:10511348
Muneyyirci-Delale O and Karacan M Hormonal treatment of bilateral proximal tubal obstruction. 1999 Jun-Aug Int J Fertil Womens Med pmid:10499742
Mendoza-Rodríguez CA et al. Variations of progesterone receptor and c-fos gene expression in the rat uterus after treatment with norethisterone and its A-ring reduced metabolites. 1999 Contraception pmid:10494488
Weisberg E et al. Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring. 1999 Contraception pmid:10494485
Weisberg E et al. A comparative study of two contraceptive vaginal rings releasing norethindrone acetate and differing doses of ethinyl estradiol. 1999 Contraception pmid:10494484
Alexandersen P et al. Monofluorophosphate combined with hormone replacement therapy induces a synergistic effect on bone mass by dissociating bone formation and resorption in postmenopausal women: a randomized study. 1999 J. Clin. Endocrinol. Metab. pmid:10487657
Engmann L et al. Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study. 1999 Am. J. Obstet. Gynecol. pmid:10486466
Rugarn O et al. Effects of estradiol, progesterone, and norethisterone on regional concentrations of galanin in the rat brain. 1999 Peptides pmid:10477130
Archer DF et al. Uterine bleeding in postmenopausal women on continuous therapy with estradiol and norethindrone acetate. Endometrium Study Group. 1999 Obstet Gynecol pmid:10472853
Gravholt CH et al. Reduced androgen levels in adult turner syndrome: influence of female sex steroids and growth hormone status. 1999 Clin. Endocrinol. (Oxf) pmid:10468952
van Hoof HJ et al. Female sex hormone replacement therapy increases serum free 1,25-dihydroxyvitamin D3: a 1-year prospective study. 1999 Clin. Endocrinol. (Oxf) pmid:10468912
Paul AC and Choy CC Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. 1999 Br J Obstet Gynaecol pmid:10430209
Geisler J et al. Plasma oestrogen fractions in postmenopausal women receiving hormone replacement therapy: influence of route of administration and cigarette smoking. 1999 J. Endocrinol. pmid:10425465
Duncan AC et al. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. 1999 J. Clin. Endocrinol. Metab. pmid:10404811
Vestergaard P et al. Effect of sex hormone replacement on the insulin-like growth factor system and bone mineral: a cross-sectional and longitudinal study in 595 perimenopausal women participating in the Danish Osteoporosis Prevention Study. 1999 J. Clin. Endocrinol. Metab. pmid:10404791
Eriksen EF et al. Hormone replacement therapy prevents osteoclastic hyperactivity: A histomorphometric study in early postmenopausal women. 1999 J. Bone Miner. Res. pmid:10404024